Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$191.17 - $325.63 $83,350 - $141,974
-436 Reduced 2.79%
15,187 $4.95 Million
Q4 2023

Feb 14, 2024

SELL
$160.99 - $215.69 $94,340 - $126,394
-586 Reduced 3.62%
15,623 $2.98 Million
Q3 2023

Nov 21, 2023

BUY
$194.33 - $283.97 $1.76 Million - $2.58 Million
9,077 Added 127.27%
16,209 $3.23 Million
Q2 2023

Aug 22, 2023

SELL
$223.05 - $302.68 $3.52 Million - $4.77 Million
-15,761 Reduced 68.85%
7,132 $49,000
Q4 2022

Jan 26, 2023

SELL
$204.38 - $296.82 $30,248 - $43,929
-148 Reduced 0.64%
22,893 $0
Q3 2022

Oct 28, 2022

BUY
$195.21 - $310.53 $109,512 - $174,207
561 Added 2.5%
23,041 $6.42 Million
Q2 2022

Aug 02, 2022

BUY
$115.91 - $214.48 $2.61 Million - $4.82 Million
22,480 New
22,480 $4.66 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.